Want to create an interactive transcript for this episode?
Podcast: A Health Podyssey
Episode: James Robinson On The Drug Market, Innovation, Biosimilars, and What The French Get Right
Description: In our multi-payer health care system, the pharmaceutical market involves the complex interplay of manufacturers, insurers, prescribers, and patients. Each seeks to protect its own interest, which can be counterproductive for overall system efficiency.The United States also has a high rate of generic drug use, which is considered a success story as the introduction of generics can rapidly and dramatically reduce drug prices. But we've had much less success with biosimilars, the generic equivalent of high-cost biologic drugs.James Robinson from the University of California, Berkeley School of Public Health joins A Health Podyssey...